NEOGENOMICS INC ·

NEO 8-K 2026-10-05

NEOGENOMICS INC (NEO) 8-K dated 2026-10-05 — accession 0001077183-26-000069. This URL is the filing, not the NEO hub.

NEOGENOMICS INC (NEO) is a diagnostics & research company listed on US.

NEO: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02, 5.02, 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NEO revenue for 2025-12-31 was $727.3M. Net income was -$108.0M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. NEO currently screens at market cap $924.0M.

Not investment advice. The NEO SEC hub lists recent forms. The stock page is the research view.

Guidance
guidance,” “enable,” “position,” “potential” and other words of similar meaning, although not all forward-looking statements inc

Why it matters

Source on EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr